Cardiac Biomarkers Market 2023 : Industry Analysis, Trends, Segmentation, Regional Overview And Forecast 2032

Posted by Amruta Pritam on December 13th, 2023

The Cardiac Biomarkers Global Market Report 2023, provides comprehensive information on the cardiac biomarkers market across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.

Learn More On The Cardiac Biomarkers Market’s Growth:

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-global-market-report

As per The Business Research Company’s Cardiac Biomarkers Global Market Report 2023, the global cardiac biomarkers market size is expected to grow from .22 billion in 2022 to .22 billion in 2023 at a compound annual growth rate (CAGR) of 13.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The cardiac biomarkers market size is expected to reach .88 billion in 2027 at a CAGR of 12.8%.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=10234&type=smp

Technological advancements are a key trend gaining popularity in the cardiac biomarker market. Companies operating in the cardiac biomarker market are adopting new technologies to sustain their position in the market. For instance, in April 2021, Roche Diagnostics, a Switzerland-based healthcare company, introduced five new solutions for two significant cardiac biomarkers, highly sensitive cardiac troponin T (cTnT-hs) and the N-terminal pro-brain natriuretic peptide test (NT-proBNP), using Elecsys technology. These solutions support cardiac risk identification and improve diagnosis and help identify cardiovascular risk, better diagnose patients and support early treatment.

The cardiac biomarkers market is segmented:
1) By Biomarkers Type: Creatine Kinase (CK-Mb), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarker Types
2) By Location Of Testing: Point Of Care Testing, Laboratory Testing
3) By Application: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome (ACS), Atherosclerosis, Other Applications
4) By End User: Hospitals, Specialty Clinics

North America was the largest region in the cardiac biomarkers market in 2022.

The table of contents in TBRC’s cardiac biomarkers market report includes:

1. Executive Summary

2. Cardiac Biomarkers Market Characteristics

3. Cardiac Biomarkers Market Trends And Strategies

4. Cardiac Biomarkers Market - Macro Economic Scenario

5. Cardiac Biomarkers Market Size And Growth

.....................

26. Africa Cardiac Biomarkers Market

27. Cardiac Biomarkers Market Competitive Landscape And Company Profiles

28. Key Mergers And Acquisitions In The Cardiac Biomarkers Market

29. Cardiac Biomarkers Market Future Outlook and Potential Analysis

30. Appendix 

Learn About Us: 

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.

Contact Us: 

The Business Research Company 
Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info